What is Bracane?
Bracane Company, Inc. operates as a prominent Clinical Research Organization (CRO) in the United States, specializing in comprehensive market, consumer, and clinical research. The company leverages data analytics, survey design, and evaluations to provide clients with strategic insights. Its service portfolio extends to clinical operation support, professional staffing, and program management, designed to navigate diverse global regulatory landscapes. Bracane is dedicated to enhancing client decision-making through quality-driven research and customer satisfaction, supporting the achievement of project objectives.
How much funding has Bracane raised?
Bracane has raised a total of $107K across 1 funding round:
Debt
$107K
Debt (2021): $107K with participation from PPP
Key Investors in Bracane
PPP
Public-Private Partnership
What's next for Bracane?
With the recent major strategic investment and a substantial overall capital base of $107K, Bracane is well-positioned for its next phase of growth. This late-stage funding suggests a focus on scaling operations, expanding market reach, and potentially investing in advanced research technologies or broadening its service offerings. The company's strategic capital will likely be directed towards solidifying its market leadership and further enhancing its capabilities in clinical operations and data analysis to meet evolving industry demands.
See full Bracane company page
